Life Sciences M&A transactions

While much of our work in this space is highly confidential, we are pleased to showcase a selection of our completed M&A transactions on this page.  In the last three years, we have worked with more than 170 companies. We completed strategic reviews, feasibility studies, sell-side transactions, and buy-side projects. Many clients return to us regularly as they progress along their M&A trajectory. 

We support a broad set of M&A transactions, including:

1. Mergers
2. Acquisitions – share or asset purchases
3. Management-led buyouts
4. Disposals (assets and stock)
5. Specialist Commercial Due Diligence (CDD) to support internal M&A divisions

Pivotal Scientific staff members have strong connections with many life science companies and their owners. This includes manufacturers, distributors, and resellers.

They also work with over 30 private equity and investment groups, which helps to grow our network. We are therefore ideally placed to promote conversations and introductions between parties of all interests. Explore our portfolio of successful M&A projects below.

Click on each logo to learn more about the strategic reasons behind the acquisitions or divestitures, and how Pivotal Scientific played a pivotal role in facilitating these M&A transactions.